Insmed Inc (NASDAQ:INSM)
| 20.75 BATS BZX Real-Time Price As of 3:18pm ET |  -0.92 / -4.25%Today’s Change | 16.41 Today|||52-Week Range 28.94 | +3.85% Year-to-Date |
Latest INSM News | Press Releases
| EMERALD MUTUAL FUND ADVISERS TRUST Buys 3, Sells 2 in 4th Quarter Feb 03 / GuruFocus News - Paid Partner Content | Top 5 4th Quarter Trades of EMERALD ADVISERS, LLC Feb 03 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 21.67 |
| Today’s open | 21.45 |
| Day’s range | 20.54 - 21.79 |
| Volume | 28,705 |
| Average volume (3 months) | 1,434,859 |
| Market cap | $2.9B |
Data as of 3:18pm ET, 02/07/2023
Growth & Valuation
| Earnings growth (last year) | -28.67% |
| Earnings growth (this year) | +4.53% |
| Earnings growth (next 5 years) | -54.45% |
| Revenue growth (last year) | +14.63% |
| P/E ratio | NM |
| Price/Sales | 16.20 |
| Price/Book | 6.25 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRTXMirati Therapeutics ... | +1.21 | +2.35% |
| PBHPrestige Consumer He... | -0.09 | -0.15% |
| GLPGGalapagos NV | +0.02 | +0.05% |
| RVNCRevance Therapeutics... | -0.55 | -1.60% |
Data as of 3:19pm ET, 02/07/2023
Financials
| Next reporting date | February 23, 2023 |
| EPS forecast (this quarter) | -$1.04 |
| Annual revenue (last year) | $188.5M |
| Annual profit (last year) | -$434.7M |
| Net profit margin | -230.63% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bridgewater, New Jersey |
Forecasts
